As previously documented[10, 12, 14, 23, 24], the diagnostic yield of AFP for HCC is significantly lower when using a control group including more advanced liver disease patients [10, 24], which is comparable to this study. This evidence concerns the gene AFP and hepatocellular carcinoma.